Literature DB >> 21111388

Exploring successful community pharmacist-physician collaborative working relationships using mixed methods.

Margie E Snyder1, Alan J Zillich, Brian A Primack, Kristen R Rice, Melissa A Somma McGivney, Janice L Pringle, Randall B Smith.   

Abstract

BACKGROUND: Collaborative working relationships (CWRs) between community pharmacists and physicians may foster the provision of medication therapy management services, disease state management, and other patient care activities; however, pharmacists have expressed difficulty in developing such relationships. Additional work is needed to understand the specific pharmacist-physician exchanges that effectively contribute to the development of CWR. Data from successful pairs of community pharmacists and physicians may provide further insights into these exchange variables and expand research on models of professional collaboration.
OBJECTIVE: To describe the professional exchanges that occurred between community pharmacists and physicians engaged in successful CWRs, using a published conceptual model and tool for quantifying the extent of collaboration.
METHODS: A national pool of experts in community pharmacy practice identified community pharmacists engaged in CWRs with physicians. Five pairs of community pharmacists and physician colleagues participated in individual semistructured interviews, and 4 of these pairs completed the Pharmacist-Physician Collaborative Index (PPCI). Main outcome measures include quantitative (ie, scores on the PPCI) and qualitative information about professional exchanges within 3 domains found previously to influence relationship development: relationship initiation, trustworthiness, and role specification.
RESULTS: On the PPCI, participants scored similarly on trustworthiness; however, physicians scored higher on relationship initiation and role specification. The qualitative interviews revealed that when initiating relationships, it was important for many pharmacists to establish open communication through face-to-face visits with physicians. Furthermore, physicians were able to recognize in these pharmacists a commitment for improved patient care. Trustworthiness was established by pharmacists making consistent contributions to care that improved patient outcomes over time. Open discussions regarding professional roles and an acknowledgment of professional norms (ie, physicians as decision makers) were essential.
CONCLUSIONS: The findings support and extend the literature on pharmacist-physician CWRs by examining the exchange domains of relationship initiation, trustworthiness, and role specification qualitatively and quantitatively among pairs of practitioners. Relationships appeared to develop in a manner consistent with a published model for CWRs, including the pharmacist as relationship initiator, the importance of communication during early stages of the relationship, and an emphasis on high-quality pharmacist contributions.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21111388      PMCID: PMC3004536          DOI: 10.1016/j.sapharm.2009.11.008

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  16 in total

Review 1.  Economic evaluations of clinical pharmacy services--1988-1995. The Publications Committee of the American College of Clinical Pharmacy.

Authors:  G T Schumock; P D Meek; P A Ploetz; L C Vermeulen
Journal:  Pharmacotherapy       Date:  1996 Nov-Dec       Impact factor: 4.705

2.  Nurses' and resident physicians' perceptions of the process of collaboration in an MICU.

Authors:  J G Baggs; M H Schmitt
Journal:  Res Nurs Health       Date:  1997-02       Impact factor: 2.228

3.  The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program.

Authors:  Carole W Cranor; Barry A Bunting; Dale B Christensen
Journal:  J Am Pharm Assoc (Wash)       Date:  2003 Mar-Apr

4.  Development of an instrument to measure collaboration and satisfaction about care decisions.

Authors:  J G Baggs
Journal:  J Adv Nurs       Date:  1994-07       Impact factor: 3.187

5.  Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.

Authors:  L L Leape; D J Cullen; M D Clapp; E Burdick; H J Demonaco; J I Erickson; D W Bates
Journal:  JAMA       Date:  1999-07-21       Impact factor: 56.272

6.  Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension.

Authors:  P E Bogden; R D Abbott; P Williamson; J K Onopa; L M Koontz
Journal:  J Gen Intern Med       Date:  1998-11       Impact factor: 5.128

7.  Collaborative working relationships between pharmacists and physicians: an exploratory study.

Authors:  Kelly A Brock; William R Doucette
Journal:  J Am Pharm Assoc (2003)       Date:  2004 May-Jun

8.  Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0).

Authors: 
Journal:  J Am Pharm Assoc (2003)       Date:  2008 May-Jun

9.  The association between interdisciplinary collaboration and patient outcomes in a medical intensive care unit.

Authors:  J G Baggs; S A Ryan; C E Phelps; J F Richeson; J E Johnson
Journal:  Heart Lung       Date:  1992-01       Impact factor: 2.210

10.  Evaluation of pharmacists' barriers to the implementation of medication therapy management services.

Authors:  Jody L Lounsbery; Christopher G Green; Marialice S Bennett; Craig A Pedersen
Journal:  J Am Pharm Assoc (2003)       Date:  2009 Jan-Feb
View more
  34 in total

1.  Validation of the Physician-Pharmacist Collaborative Index for physicians in Malaysia.

Authors:  Renukha Sellappans; Chirk Jenn Ng; Pauline Siew Mei Lai
Journal:  Int J Clin Pharm       Date:  2015-09-25

2.  Factors associated with comprehensive medication review completion rates: A national survey of community pharmacists.

Authors:  Margie E Snyder; Heather A Jaynes; Stephanie A Gernant; Wendy M Lantaff; William R Doucette; Karen Suchanek Hudmon; Susan M Perkins
Journal:  Res Social Adm Pharm       Date:  2019-08-02

3.  Interprofessional communication between community pharmacists and general practitioners: a qualitative study.

Authors:  Marina Weissenborn; Walter E Haefeli; Frank Peters-Klimm; Hanna M Seidling
Journal:  Int J Clin Pharm       Date:  2017-03-17

4.  Cooperation between community pharmacists and general practitioners in eastern Germany: attitudes and needs.

Authors:  Anna-Franziska Wüstmann; Carsten Haase-Strey; Thomas Kubiak; Christoph Alexander Ritter
Journal:  Int J Clin Pharm       Date:  2013-04-11

5.  Assessment of pharmacists' job satisfaction and job related stress in Amman.

Authors:  Doaa Al Khalidi; Mayyada Wazaify
Journal:  Int J Clin Pharm       Date:  2013-06-27

6.  Impact of team-versus ward-aligned clinical pharmacy on unintentional medication discrepancies at admission.

Authors:  Sharon M Byrne; Tamasine C Grimes; Marie-Claire Jago-Byrne; Mairéad Galvin
Journal:  Int J Clin Pharm       Date:  2016-12-22

7.  Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting.

Authors:  Susanne B Haga; Jivan Moaddeb; Rachel Mills; Deepak Voora
Journal:  Pharmacogenomics       Date:  2017-02-22       Impact factor: 2.533

8.  Prescriber Implementation of STOPP/START Recommendations for Hospitalised Older Adults: A Comparison of a Pharmacist Approach and a Physician Approach.

Authors:  Kieran Dalton; Denis O'Mahony; David O'Sullivan; Marie N O'Connor; Stephen Byrne
Journal:  Drugs Aging       Date:  2019-03       Impact factor: 3.923

Review 9.  Teamwork assessment in internal medicine: a systematic review of validity evidence and outcomes.

Authors:  Rachel D A Havyer; Majken T Wingo; Nneka I Comfere; Darlene R Nelson; Andrew J Halvorsen; Furman S McDonald; Darcy A Reed
Journal:  J Gen Intern Med       Date:  2013-12-11       Impact factor: 5.128

10.  Evaluation of a Danish pharmacist student-physician medication review collaboration model.

Authors:  Susanne Kaae; Ellen Westh Sørensen; Lotte Stig Nørgaard
Journal:  Int J Clin Pharm       Date:  2014-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.